Goldline Pharmaceutical Ltd () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

42.0 k (-36.36%) Volume

Shareholding (May 2026)

FII

0.00%

Held by 0 FIIs

DII

20.29%

Held by 0 DIIs

Promoter

79.71%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 42 Cr ()

P/E

10.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

2.91

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Announcement under Regulation 30 (LODR)-Change in Management

09-Jun-2026 | Source : BSE

Intimation of Appointment of M/s. Kunal Dutt & Associates Practicing Company Secretaries Membership No. FCS 8831 as Internal Auditor of the Company.

Outcome Of Board Meeting Held Today I.E. 09Th June 2026

09-Jun-2026 | Source : BSE

Outcome of Board Meeting held today i.e. 09th June 2026 for approval of financials results for the half year and year ended 31st March 2026.

Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 09Th June 2026

09-Jun-2026 | Source : BSE

Outcome of Board Meeting held today i.e. 09th June 2026 for approval of financial results for the half year and year ended 31st march 2026.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

3.65

Debt to EBITDA (avg)

1.32

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.33

Tax Ratio

23.56%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

20.29%

ROCE (avg)

29.36%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.91

EV to EBIT

7.48

EV to EBITDA

7.22

EV to Capital Employed

2.19

EV to Sales

1.61

PEG Ratio

Dividend Yield

ROCE (Latest)

29.36%

ROE (Latest)

28.91%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bollinger Bands

KST

Dow Theory

OBV

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : May 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Swapan Premprakash Khandelwal (39.85%)

Highest Public shareholder

Sumit Bilgaiyan (7.03%)

Individual Investors Holdings

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Goldline Pharmac"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Goldline Pharmac"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Goldline Pharmac"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Goldline Pharmac"
  }
]

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."